Europe's National Medical Technology Innovation Centres will advance R&D
This article was originally published in Clinica
Executive Summary
The European medtech association, Eucomed, is hoping its members will soon profit from the European Commission's pledge to support initiatives targeted at promoting innovative products, a policy enshrined in the Lisbon agenda, writes Amanda Maxwell. Speaking to Clinica in an interview at Eucomed's Brussels headquarters last week, Eucomed director general Maurice Wagner said that his association is on the point of launching a new initiative to set up National Medical Technology Innovation Centres (NMTICs) in as many Eucomed national association countries as feasible.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.